[EN] 5-[(1S)-1-(4-BROMOPHENOXY)ETHYL]-2H-TETRAZOLE DERIVATIVES AND RELATED COMPOUNDS AS CLC-1 ION CHANNEL INHIBITORS FOR TREATING NEUROMUSCULAR DISORDERS<br/>[FR] DÉRIVÉS DE 5-[(1S)-1-(4-BROMOPHÉNOXY)ÉTHYL]-2 H-TÉTRAZOLE ET COMPOSÉS APPARENTÉS EN TANT QU'INHIBITEURS DE CANAL IONIQUE CLC-1 POUR LE TRAITEMENT DE TROUBLES NEUROMUSCULAIRES
申请人:NMD PHARMA AS
公开号:WO2020254558A1
公开(公告)日:2020-12-24
The present disclosure relates to compounds suitable for treating, ameliorating and/or preventing neuromuscular disorders, including the reversal of drug-induced neuromuscular blockade. The compounds as defined herein can inhibit the ClC-1 ion channel.
本公开涉及适用于治疗、改善和/或预防神经肌肉疾病的化合物,包括逆转药物诱导的神经肌肉阻滞。本文定义的化合物可以抑制ClC-1离子通道。